Showing results (81-90 of 88) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Multiple Sclerosis and Related Disorders|February 26, 2022
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in ItalyRiccardo Giossi, Alessandra Consonni, Valentina Torri Clerici, et al.Neuro-Oncology Advances|July 10, 2020
Expansion of effector and memory T cells is associated with increased survival in recurrent glioblastomas treated with dendritic cell immunotherapyMarica Eoli, Cristina Corbetta, Elena Anghileri, et al.Orphanet Journal of Rare Diseases|March 12, 2025
Toward European harmonization of national myasthenia gravis registries: modified Delphi procedure-based expert consensus on collectable dataAbderhmane Slioui, Giulia Tammam, Fiammetta Vanoli, et al.The Lancet. Neurology|January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled studyCarlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.Human Vaccines & Immunotherapeutics|May 5, 2026
Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trialsFaye Yu, Eugene Myshkin, Brandon Nguyen, et al.Annals of Clinical and Translational Neurology|October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravisNili Avidan, Rozen Le Panse, Hanne F Harbo, et al.Journal of the Neurological Sciences|November 28, 2025
Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational studyVincenzo Di Stefano, Nicasio Rini, Carlo Antozzi, et al.JAMA Neurology|February 14, 2018
Interpreting Genetic Variants in Titin in Patients With Muscle DisordersMarco Savarese, Lorenzo Maggi, Anna Vihola, et al.Pageof 9